Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Serbia Health minister wants stricter public usage rules for smoking…
  • Bahrain Final stage of HTP digital stamp system to be implemented…
  • Ireland Tobacco and nicotine products bill is adopted…
  • United States Menthol cigarette proposed rule review to continue into 2024…
  • Brazil Dates released for consultation of resolution banning heated tobacco…
  • Azerbaijan National Assembly approves tax amendment in third reading…
  • Brazil Public consultation to review e-cig ban to be opened…
  • Czech Republic Tax bill sent for publication…
  • Portugal Parliament approves heated tobacco flavour ban bill…
  • Finland Tax bill changed to include liquid smokeless nicotine products…
  • United Kingdom New heated tobacco tax rate in effect…
  • Portugal State Budget 2024 approved, increased heated tobacco tax to come…
View all
News analysis

IQOS 3 is approved for sale in the US as FDA finds ‘no new concerns’

Written by || 9th December 2020 || News analysis | Heated tobacco | IQOS | Major brands | Regulation and legislation | North America United States

The US Food and Drug Administration (FDA) has issued a marketing order authorising the sale of Philip Morris International (PMI)’s IQOS 3 holder and charger ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA gives the green light for IQOS roll-out onto the US market
US FDA grants modified risk orders to PMI’s Iqos and Marlboro HeatSticks
HnB growth provides the silver lining to PMI’s declining overall earnings

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy. 

    © 2023 Tamarind Media Limited (T/A TobaccoIntelligence)

    TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence, does not accept any liability or responsibility for information or views published.